4BASEBIO PLC EO 1

88Q XETRA / Francfort Healthcare & Biotech United Kingdom
5.45
2.83 %

4basebio focuses on developing gene therapy solutions using non-viral nucleic acids.

Performance & Momentum

6 Months 34.16 %
1 Year 59.23 %
3 Years 17.83 %
5 Years 30.72 %

Similar stocks to 4BASEBIO PLC EO 1

Anantys Community

Be the first to share your analysis on 4BASEBIO PLC EO 1.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases